163 related articles for article (PubMed ID: 21684681)
1. GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response.
Chen B; Rao X; House MG; Nephew KP; Cullen KJ; Guo Z
Cancer Lett; 2011 Oct; 309(1):37-45. PubMed ID: 21684681
[TBL] [Abstract][Full Text] [Related]
2. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer.
Min SY; Kim HS; Jung EJ; Jung EJ; Jee CD; Kim WH
Anticancer Res; 2012 Aug; 32(8):3169-75. PubMed ID: 22843889
[TBL] [Abstract][Full Text] [Related]
4. Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas.
Peng DF; Hu TL; Schneider BG; Chen Z; Xu ZK; El-Rifai W
PLoS One; 2012; 7(10):e46214. PubMed ID: 23071548
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis.
Lee OJ; Schneider-Stock R; McChesney PA; Kuester D; Roessner A; Vieth M; Moskaluk CA; El-Rifai W
Neoplasia; 2005 Sep; 7(9):854-61. PubMed ID: 16229808
[TBL] [Abstract][Full Text] [Related]
6. DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.
Peng J; Chen B; Shen Z; Deng H; Liu D; Xie X; Gan X; Xu X; Huang Z; Chen J
Int J Clin Exp Pathol; 2015; 8(9):11042-50. PubMed ID: 26617822
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic and Glucocorticoid Receptor-Mediated Regulation of Glutathione Peroxidase 3 in Lung Cancer Cells.
An BC; Jung NK; Park CY; Oh IJ; Choi YD; Park JI; Lee SW
Mol Cells; 2016 Aug; 39(8):631-8. PubMed ID: 27484907
[TBL] [Abstract][Full Text] [Related]
8. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis.
Mohamed MM; Sabet S; Peng DF; Nouh MA; El-Shinawi M; El-Rifai W
Oxid Med Cell Longev; 2014; 2014():787195. PubMed ID: 24790704
[TBL] [Abstract][Full Text] [Related]
10. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.
Peng DF; Razvi M; Chen H; Washington K; Roessner A; Schneider-Stock R; El-Rifai W
Gut; 2009 Jan; 58(1):5-15. PubMed ID: 18664505
[TBL] [Abstract][Full Text] [Related]
11. MiR-921 directly downregulates GPx3 in A549 lung cancer cells.
Choi JY; An BC; Jung IJ; Kim JH; Lee SW
Gene; 2019 Jun; 700():163-167. PubMed ID: 30898707
[TBL] [Abstract][Full Text] [Related]
12. Role of neurofilament light polypeptide in head and neck cancer chemoresistance.
Chen B; Chen J; House MG; Cullen KJ; Nephew KP; Guo Z
Mol Cancer Res; 2012 Mar; 10(3):305-15. PubMed ID: 22246235
[TBL] [Abstract][Full Text] [Related]
13. GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer.
Pelosof L; Yerram S; Armstrong T; Chu N; Danilova L; Yanagisawa B; Hidalgo M; Azad N; Herman JG
Epigenetics; 2017 Jul; 12(7):540-550. PubMed ID: 27918237
[TBL] [Abstract][Full Text] [Related]
14. GPX3 promoter is methylated in chronic myeloid leukemia.
Yao DM; Zhou JD; Zhang YY; Yang L; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J
Int J Clin Exp Pathol; 2015; 8(6):6450-7. PubMed ID: 26261521
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma.
Chen H; Zheng Z; Kim KY; Jin X; Roh MR; Jin Z
Oncol Rep; 2016 Nov; 36(5):2737-2744. PubMed ID: 27600457
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer.
Zhang X; Zheng Z; Yingji S; Kim H; Jin R; Renshu L; Lee DY; Roh MR; Yang S
Oncol Rep; 2014 Jun; 31(6):2587-92. PubMed ID: 24788695
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation and clinical significance of GPX3 in esophageal squamous cell carcinoma.
Lin Y; Zhang Y; Chen Y; Liu Z
Pathol Res Pract; 2019 Nov; 215(11):152676. PubMed ID: 31610903
[TBL] [Abstract][Full Text] [Related]
18. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis.
Yu YP; Yu G; Tseng G; Cieply K; Nelson J; Defrances M; Zarnegar R; Michalopoulos G; Luo JH
Cancer Res; 2007 Sep; 67(17):8043-50. PubMed ID: 17804715
[TBL] [Abstract][Full Text] [Related]
19. Association between GPX3 promoter methylation and malignant tumors: A meta-analysis.
Zhou C; Hu H; Zheng Z; Chen C; Li Y; Li B; Duan S
Pathol Res Pract; 2019 Jul; 215(7):152443. PubMed ID: 31085009
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]